In conclusion, our study provides further support for the important contribution of KCa3.1 activation in the progression of atherosclerotic lesion development and composition and provides novel insights into the mechanisms of the beneficial effect of KCa3.1 inhibition on atherosclerosis. This evidence concerns the gene KCNN4 and atherosclerosis.